These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 32410877)

  • 1. Summary of international recommendations in 23 languages for patients with cancer during the COVID-19 pandemic.
    Mauri D; Kamposioras K; Tolia M; Alongi F; Tzachanis D;
    Lancet Oncol; 2020 Jun; 21(6):759-760. PubMed ID: 32410877
    [No Abstract]   [Full Text] [Related]  

  • 2. [COVID 19 and cancer: What are the consequences of the cancer care reorganization?].
    El Amrani M; Truant S; Turpin A
    Bull Cancer; 2020 May; 107(5):538-540. PubMed ID: 32359766
    [No Abstract]   [Full Text] [Related]  

  • 3. [Breast cancer management during the COVID 19 pandemic: The CNGOF takes action].
    Mathelin C; Nisand I
    Gynecol Obstet Fertil Senol; 2020 Jun; 48(6):473-474. PubMed ID: 32320812
    [No Abstract]   [Full Text] [Related]  

  • 4. A Neuroendocrine Tumor Specialty Center in New Orleans' (NOLANETS) Response to Patient Care During the COVID-19 Pandemic.
    Ramirez RA; Bren-Mattison Y; Thiagarajan R; Boudreaux JP; Marsala AJ; Ryan P; Maluccio MA
    Oncologist; 2020 Jul; 25(7):548-551. PubMed ID: 32369669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The COVID-19 outbreak: a snapshot from down under.
    van Zandwijk N; Rasko JEJ
    Expert Rev Anticancer Ther; 2020 Jun; 20(6):433-436. PubMed ID: 32419533
    [No Abstract]   [Full Text] [Related]  

  • 6. How to restructure the management of Italian oncological patients during and after COVID-19 pandemic?
    Fabi A; Ferretti G; Cognetti F
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6478-6479. PubMed ID: 32633331
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer management challenge in a developing country in COVID-19 pandemic: reflection of a group of Moroccan oncologists.
    Mrabti H; Berrada N; Raiss G; Ettahri H; Abahssain H; Bourhafour M; Sahraoui S; Errihani H
    Future Oncol; 2020 Sep; 16(26):2007-2016. PubMed ID: 32583680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to face cancer treatment in the COVID-19 era.
    Brandes AA; Di Nunno V
    Expert Rev Anticancer Ther; 2020 Jun; 20(6):429-432. PubMed ID: 32370563
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID -19 Pandemic: The Challenges for Pediatric Oncology.
    Seth R
    Indian Pediatr; 2020 Jun; 57(6):589-590. PubMed ID: 32366725
    [No Abstract]   [Full Text] [Related]  

  • 10. Oncology care in a lower middle-income country during the COVID-19 pandemic.
    Trehan A; Jain R; Bansal D
    Pediatr Blood Cancer; 2020 Aug; 67(8):e28438. PubMed ID: 32542968
    [No Abstract]   [Full Text] [Related]  

  • 11. Emergency changes in international guidelines on treatment for head and neck cancer patients during the COVID-19 pandemic.
    Chaves ALF; Castro AF; Marta GN; Junior GC; Ferris RL; Giglio RE; Golusinski W; Gorphe P; Hosal S; Leemans CR; Magné N; Mehanna H; Mesía R; Netto E; Psyrri A; Sacco AG; Shah J; Simon C; Vermorken JB; Kowalski LP
    Oral Oncol; 2020 Aug; 107():104734. PubMed ID: 32353793
    [No Abstract]   [Full Text] [Related]  

  • 12. Oncology Care Delivery in the COVID-19 Pandemic: An Opportunity to Study Innovations and Outcomes.
    Cinar P; Cox J; Kamal A; Bickel K; Krzyzanowska M; Armitage J; Ganti AK; Ward J; Wong S; Lonial S; Bosserman L
    JCO Oncol Pract; 2020 Aug; 16(8):431-434. PubMed ID: 32463764
    [No Abstract]   [Full Text] [Related]  

  • 13. Early advice on managing children with cancer during the COVID-19 pandemic and a call for sharing experiences.
    Bouffet E; Challinor J; Sullivan M; Biondi A; Rodriguez-Galindo C; Pritchard-Jones K
    Pediatr Blood Cancer; 2020 Jul; 67(7):e28327. PubMed ID: 32239747
    [No Abstract]   [Full Text] [Related]  

  • 14. Modifying Practices in GI Oncology in the Face of COVID-19: Recommendations From Expert Oncologists on Minimizing Patient Risk.
    Lou E; Beg S; Bergsland E; Eng C; Khorana A; Kopetz S; Lubner S; Saltz L; Shankaran V; Zafar SY
    JCO Oncol Pract; 2020 Jul; 16(7):383-388. PubMed ID: 32352884
    [No Abstract]   [Full Text] [Related]  

  • 15. Rehabilitation Recommendations for Multiple Sclerosis Patients during the COVID-19 Pandemic.
    Naser Moghadasi A; Azadvari M; Sahraian MA
    Arch Iran Med; 2020 Jul; 23(7):509-510. PubMed ID: 32657605
    [No Abstract]   [Full Text] [Related]  

  • 16. [Investigación en cáncer en el contexto de la pandemia de la enfermedad por SARS-CoV-2].
    Wiesner C
    Biomedica; 2020 Jun; 40(2):217-219. PubMed ID: 32673450
    [No Abstract]   [Full Text] [Related]  

  • 17. Adapting to a Pandemic - Conducting Oncology Trials during the SARS-CoV-2 Pandemic.
    Tan AC; Ashley DM; Khasraw M
    Clin Cancer Res; 2020 Jul; 26(13):3100-3103. PubMed ID: 32312892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addressing the Mental Health Challenges of Cancer Care Workers in LMICs During the Time of the COVID-19 Pandemic.
    Datta SS; Mukherjee A; Ghose S; Bhattacharya S; Gyawali B
    JCO Glob Oncol; 2020 Oct; 6():1490-1493. PubMed ID: 33017180
    [No Abstract]   [Full Text] [Related]  

  • 19. Milan 2020: COVID-19, neuro-oncology and much more.
    Finocchiaro G
    J Neurooncol; 2020 May; 148(1):201-202. PubMed ID: 32285310
    [No Abstract]   [Full Text] [Related]  

  • 20. Rethinking Clinical Trials Reform During the COVID-19 Pandemic.
    Nabhan C; Choueiri TK; Mato AR
    JAMA Oncol; 2020 Sep; 6(9):1327-1329. PubMed ID: 32761101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.